Interestingly, treatment with a well‐known Akt inhibitor, MK2206, significantly reduced CHEK1 expression in CRC cells (Supplementary Figure S6G) by reducing the transcriptional activity of CHEK1 (Supplementary Figure S6H). This evidence concerns the gene CHEK1 and colorectal carcinoma.